MyFinsight
Home
Compare
Blog
About
Gross proceeds from
issuance of common shares
$2,720,561
Proceeds for warrants
issued under the...
$4,962
Proceeds received for
performance warrants...
$1,250
something is missing
$2,467,918
Cash provided by
(used in) financing...
$1,704,979
Canceled cashflow
$1,021,794
Cash, cash
equivalent, restricted...
-$2,627,501
Canceled cashflow
$4,172,897
Represents the amount of
shares issued for...
$3,081,289
Share-based payment
arrangement, noncash expense
$1,044,222
Increase (decrease) in
accounts payable and...
$326,106
Loss on write off of
offering costs
$73,169
Amount of increase
(decrease) in operating...
-$9,841
Depreciation
$5,483
something is missing
-$898,615
Repayments on insurance
funding agreement
$92,187
Payments for offering
costs paid for future...
$30,992
Net cash used in
operating activities
-$6,758,998
Canceled cashflow
$4,540,110
Net cash used in
investing activities
-$41,400
Net loss
-$7,725,651
Prepaid expenses
$3,465,013
Increase (decrease) in
due to related...
-$25,935
Amount of increase
(decrease) in operating...
-$22,350
Operating lease - right of
use
-$9,000
Increase (decrease) in
security deposits
-$6,158
Interest receivable
$255
Amortization
-$47
Fixed asset, disposed
$1
Purchase of fixed assets
$41,400
Back
Back
Cash Flow
Conexeu Sciences Inc. (CNXU)
Conexeu Sciences Inc. (CNXU)
source: myfinsight.com